<VariationArchive VariationID="1806213" VariationName="NM_002715.4(PPP2CA):c.379del (p.Tyr127fs)" VariationType="Deletion" Accession="VCV001806213" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-04-15" DateCreated="2022-12-24" MostRecentSubmission="2022-12-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1863223" VariationID="1806213">
      <GeneList>
        <Gene Symbol="PPP2CA" FullName="protein phosphatase 2 catalytic subunit alpha" GeneID="5515" HGNC_ID="HGNC:9299" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q31.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="134194332" stop="134226073" display_start="134194332" display_stop="134226073" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="133532147" stop="133561949" display_start="133532147" display_stop="133561949" Strand="-" />
          </Location>
          <OMIM>176915</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_002715.4(PPP2CA):c.379del (p.Tyr127fs)</Name>
      <CanonicalSPDI>NC_000005.10:134201954:AAA:AA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q31.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="134201955" stop="134201955" display_start="134201955" display_stop="134201955" variantLength="1" positionVCF="134201954" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="133537646" stop="133537646" display_start="133537646" display_stop="133537646" variantLength="1" positionVCF="133537645" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>Y127fs</ProteinChange>
      <ProteinChange>Y62fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.134201957del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.134201957del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.133537648del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.133537648del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_046997.2" sequenceAccession="NG_046997" sequenceVersion="2" change="g.29118del">
            <Expression>NG_046997.2:g.29118del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001355019.2" sequenceAccession="NM_001355019" sequenceVersion="2" change="c.184del">
            <Expression>NM_001355019.2:c.184del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341948.1" sequenceAccession="NP_001341948" sequenceVersion="1" change="p.Tyr62fs">
            <Expression>NP_001341948.1:p.Tyr62fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002715.4" sequenceAccession="NM_002715" sequenceVersion="4" change="c.379del" MANESelect="true">
            <Expression>NM_002715.4:c.379del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002706.1" sequenceAccession="NP_002706" sequenceVersion="1" change="p.Tyr127fs">
            <Expression>NP_002706.1:p.Tyr127fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_149151.2" sequenceAccession="NR_149151" sequenceVersion="2" change="n.623del">
            <Expression>NR_149151.2:n.623del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002715.4(PPP2CA):c.379del (p.Tyr127fs) AND Houge-Janssens syndrome 3" Accession="RCV002470497" Version="1">
        <ClassifiedConditionList TraitSetID="46519">
          <ClassifiedCondition DB="MedGen" ID="C5193048">Houge-Janssens syndrome 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-05-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-05-06" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-12-24" MostRecentSubmission="2022-12-24">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">30595372</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="46519" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="41509" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Houge-Janssens syndrome 3</ElementValue>
                <XRef ID="MONDO:0032697" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neurodevelopmental disorder and language delay with or without structural brain abnormalities</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NEDLBA</ElementValue>
                <XRef Type="MIM" ID="618354" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HJS3</ElementValue>
                <XRef Type="MIM" ID="618354" DB="OMIM" />
              </Symbol>
              <XRef ID="C5193048" DB="MedGen" />
              <XRef ID="MONDO:0032697" DB="MONDO" />
              <XRef Type="MIM" ID="618354" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5415217" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_002715_3_PPP2CA_c_379delT" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002768026" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-05-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">30595372</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with neurodevelopmental disorder and language delay with or without structural brain abnormalities (MIM#618354). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0401 - Variant is located in a gene associated with a severe early-onset dominant condition that is intolerant to loss of function variants (gnomAD, OMIM). (SP) 0702 - Other NMD-predicted variants comparable to the one identified in this case have strong previous evidence for pathogenicity. Other variants resulting in a loss of function have previously been reported as pathogenic in individuals with neurodevelopmental disorder and language delay with or without structural brain abnormalities (MIM#618354), and all were shown to be de novo (ClinVar, PMID: 30595372). (SP) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1102 - Strong phenotype match for this individual. (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PPP2CA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_6894</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_002715.3:c.379delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="618354" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5415217" TraitType="Disease" MappingType="XRef" MappingValue="618354" MappingRef="OMIM">
        <MedGen CUI="C5193048" Name="Houge-Janssens syndrome 3" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

